Cervical cancer benefits from trabectedin combination with the ß-blocker propranolol: in vitro and ex vivo evaluations in patient-derived organoids.
Front Cell Dev Biol
; 11: 1178316, 2023.
Article
in En
| MEDLINE
| ID: mdl-37384250
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Front Cell Dev Biol
Year:
2023
Document type:
Article
Affiliation country:
Italy
Country of publication:
Switzerland